Stock up now: as soon as Trump mentions this our health authorities will banish it from the shelves
/
Banned for your own protection
A new landmark study at the University of Maryland School of Medicine found that COVID-19 patients taking a daily, low-dose aspirin to protect against cardiovascular disease significantly lowered the risk of death and complications from COVID-19.
The study found that COVID-19 patients taking aspirin were nearly 50% less likely to die in the hospital and much less likely to be admitted to the ICU and put on a ventilator.
Doctors said because the virus increases the risk of blood clots, it makes sense that aspirin would help infected patients.